Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02910999
What this trial is testing

Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 868
Large-scale testing (Phase 3)Not Yet RecruitingNCT07486687
What this trial is testing

Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early SettingEarly Stage Triple-Negative Breast CarcinomaTriple -Negative Breast Cancer+2 more
The Netherlands Cancer Institute 1,000
Large-scale testing (Phase 3)UnknownNCT02249208
What this trial is testing

Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.

Who this might be right for
Breast Cancer
Hospital Universitari Vall d'Hebron Research Institute 150
Early research (Phase 1)Study completedNCT02382640
What this trial is testing

Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule

Who this might be right for
Healthy Volunteers
Takeda 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07463768
What this trial is testing

Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 60
Large-scale testing (Phase 3)Looking for participantsNCT07188025
What this trial is testing

CtDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer

Who this might be right for
Rectal Cancer
Erasmus Medical Center 103
Not applicableStudy completedNCT00952926
What this trial is testing

Watchful Waiting. An Observational Study of Patients With Rectal Cancer After Concomitant Radiation and Chemotherapy

Who this might be right for
Rectal Cancer
Vejle Hospital 55
Testing effectiveness (Phase 2)Looking for participantsNCT06208826
What this trial is testing

A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy

Who this might be right for
Head and Neck Cancer
Tianjin Medical University Cancer Institute and Hospital 268
Testing effectiveness (Phase 2)Ended earlyNCT01759238
What this trial is testing

Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastases
Universitätsklinikum Hamburg-Eppendorf 1
Not applicableLooking for participantsNCT06780735
What this trial is testing

Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy

Who this might be right for
Breast NeoplasmsBreast Cancer
National Cancer Center, Korea 128
Large-scale testing (Phase 3)Looking for participantsNCT07414758
What this trial is testing

Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 68
Testing effectiveness (Phase 2)Study completedNCT00791778
What this trial is testing

Comparison of Nexavar/Placebo as Maintenance Therapy for Patients With Advanced Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian Neoplasms
Bayer 246
Testing effectiveness (Phase 2)Looking for participantsNCT06176885
What this trial is testing

Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
yue junhan 36
Large-scale testing (Phase 3)Study completedNCT00775385
What this trial is testing

TAilored Post-Surgical Therapy in Early Stage NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 152
Post-approval studies (Phase 4)Ended earlyNCT02441517
What this trial is testing

Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Astellas Pharma Global Development, Inc. 4
Testing effectiveness (Phase 2)Ended earlyNCT00612677
What this trial is testing

Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 1
Post-approval studies (Phase 4)Ended earlyNCT03490396
What this trial is testing

Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients

Who this might be right for
Oral Mucositis
Midatech Pharma US Inc. 28
Not applicableLooking for participantsNCT06491862
What this trial is testing

RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil

Who this might be right for
Non-squamous Non-Small Cell Lung Cancer
AstraZeneca 250
Testing effectiveness (Phase 2)Ended earlyNCT02191566
What this trial is testing

S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy

Who this might be right for
Stomach Cancer
Kangbuk Samsung Hospital 8
Large-scale testing (Phase 3)Study completedNCT00003422
What this trial is testing

Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed

Who this might be right for
Colorectal Cancer
Medical Research Council 1,800
Next Page